| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Martin Wilson | CLO | 2026-09-11 | 75,364 | $3.40 | $256.46kSell |
| Martin Wilson | CLO | 2026-08-18 | 631 | $3.38 | $2.13kSell |
| Gaurav Shah | CEO | 2026-08-18 | 2,293 | $3.38 | $7.75kSell |
| Gaurav Shah | CEO | 2026-08-13 | 2,837 | $3.38 | $9.59kSell |
| Martin Wilson | CLO | 2026-08-13 | 3,493 | $3.38 | $11.81kSell |
| Sarbani Chaudhuri | CCO | 2026-08-11 | 4,701 | $3.50 | $16.45kSell |
| Christopher James Stevens | COO | 2026-08-11 | 36,658 | $3.50 | $128.27kSell |
| Gaurav Shah | CEO | 2026-05-21 | 76,490 | $1.69 | $129.34kBuy |
| Gaurav Shah | CEO | 2026-05-21 | 55,684 | $3.09 | $171.84kSell |
| Martin Wilson | General Counsel | 2026-05-19 | 662 | $3.01 | $2.00kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Roderick Wong | 31.46% | 34,536,591 | $104.30M | Insider |
| Rtw Investments LP | 30.70% | 33,696,243 | $101.76M | Insider |
| Devon Park Associates LP | 2.96% | 3,253,566 | $9.83M | Insider |
| Devang Kantesaria | 2.95% | 3,243,709 | $9.80M | Insider |
| Devon Park Bioventures LP | 2.95% | 3,243,709 | $9.80M | Insider |
| Rho Ventures IV Qp LP | 2.61% | 2,870,584 | $8.67M | Insider |
| Care Capital II LLC | 2.07% | 2,277,139 | $6.88M | Insider |
| Argeris N. Karabelas | 2.07% | 2,277,139 | $6.88M | Insider |
| Medimmune Ventures Inc | 1.92% | 2,106,818 | $6.36M | Insider |
| Gaurav Shah | 1.88% | 2,067,411 | $6.24M | Insider |